All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Sangamo BioSciences, Inc. Dr. Fyodor D Urnov Strategic Partnership II A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells $2,760,540
Human BioMolecular Research Institute Dr. John R Cashman Patent Assistance Fund Awards Intellectual Property for Stem Cell-Related Inventions – HBRI $50,000
University of California, San Francisco Karin Immergluck PhD Patent Assistance Fund Awards Patent Assistance Fund Proposal – UCSF $87,257
University of California, Davis David McGee Patent Assistance Fund Awards CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies – UCD $48,595
University of California, Santa Barbara Bernadette McCafferty Patent Assistance Fund Awards Intellectual Property in Regenerative Bioengineering from CIRM funded research in regenerative medicine at the University of California, Santa Barbara. $23,564
University of California, Irvine Ronnie Hanecak Patent Assistance Fund Awards CIRM Patent Assistance Fund Application – UCI $46,155
University of California, Los Angeles Adele Rennie Patent Assistance Fund Awards Patent Assistance Fund – UCLA $84,973
Stanford University Katharine Ku Patent Assistance Fund Awards Funding for Patent Applications for CIRM-funded Inventions out of Stanford University $3,525
University of California, San Diego Dr. Rubén D. Flores Patent Assistance Fund Awards Patent Assistance Fund Application – UCSD $38,162
University of California, San Diego Dr. Lawrence S. B. Goldstein Early Translational from Disease Team Conversion Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis $4,139,754
University of California, Los Angeles Dr. Irvin SY Chen Early Translational from Disease Team Conversion Development of a humanized mouse model for testing anti-HIV HSPC gene therapy strategies in HIV-1 infected mice. $1,505,000
University of California, Los Angeles Dr. Stanley Nelson Early Translational from Disease Team Conversion Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $1,823,545
University of California, Los Angeles Dr. Robert Reiter MD Early Translational IV Clinical Development of an N-cadherin Antibody to Target Cancer Stem Cells $4,075,668
Human BioMolecular Research Institute Dr. John R Cashman Early Translational IV Improving Existing Drugs for Long QT Syndrome type 3 (LQT3) by hiPSC Disease-in-Dish Model $6,361,369
Numerate, Inc. Dr. John H Griffin Early Translational IV Use of human iPSC-derived neurons from Huntington’s Disease patients to develop novel, disease-modifying small molecule structural corrector drug candidates targeting the unique, neurotoxic conformation of mutant huntingtin $520,015
University of California, Los Angeles Dr. Jerome A. Zack Ph.D. Early Translational IV Stem Cell Programming With Chimeric Antigen Receptors to Eradicate HIV Infection $4,925,166
University of California, Los Angeles Dr. Gerald Lipshutz Early Translational IV Gene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders $1,801,629
University of California, Los Angeles Dr. Donald B. Kohn Early Translational IV Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells $1,651,884
Salk Institute for Biological Studies Dr. Inder M. Verma Early Translational IV Development of a cell and gene based therapy for hemophilia $2,298,634
The Scintillon Institute Dr. Stuart A Lipton Early Translational IV Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke $1,103,185
Sanford Burnham Prebys Medical Discovery Institute Dr. Stuart A Lipton Early Translational IV Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke $1,020,815
University of California, San Diego Professor Alysson R Muotri Early Translational IV A drug-screening platform for autism spectrum disorders using human astrocytes $1,656,456
Cedars-Sinai Medical Center Dr. Dan Gazit Early Translational IV Gene Targeting to Endogenous Stem Cells for Segmental Bone Fracture Healing $5,121,514
Stanford University Dr. Michele Calos Early Translational IV Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
Gladstone Institutes, J. David Dr. Steve M. Finkbeiner Early Translational IV Development of Novel Autophagy Inducers to Block the Progression of and Treat Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases $2,049,053
University of California, Irvine Dr. Magdalene J Seiler Early Translational IV Restoring vision by sheet transplants of retinal progenitors and retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs) $3,998,948
ViaCyte, Inc. Howard Foyt Strategic Partnership I Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes $9,475,070
Bluebird Bio David M. Davidson Strategic Partnership I A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia by Transplantation of Autologous Hematopoietic Stem Cells Transduced with the Lentiviral Vector LentiGlobin® Encoding the Human β-A-T87Q-… $0
FUJIFILM Cellular Dynamics Deborah Requesens hPSC Repository The CIRM Human Pluripotent Stem Cell Biorepository – A Resource for Safe Storage and Distribution of High Quality iPSCs $9,942,175
Cellular Dynamics International Dr. Thomas J Novak hiPSC Derivation Generation and characterization of high-quality, footprint-free human induced pluripotent stem cell lines from 3,000 donors to investigate multigenic diseases $16,000,000
University of California, San Diego Dr. Joseph G. Gleeson Tissue Collection for Disease Modeling CIRM Tissue Collection for Neurodevelopmental Disabilities $830,426
University of California, San Diego Dr. Kang Zhang M.D. Tissue Collection for Disease Modeling Generation of fibroblast cell lines in patients with common blinding eye diseases $1,034,425
Stanford University Dr. Joseph C. Wu Tissue Collection for Disease Modeling Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases $1,291,832
University of California, San Diego Dr. James Brewer Tissue Collection for Disease Modeling Collection of skin biopsies to prepare fibroblasts from patients with Alzheimer’s disease and cognitively healthy elderly controls $643,693
Stanford University Dr. Joachim Franz Hallmayer Tissue Collection for Disease Modeling Induced pluripotent stem cells from children with autism spectrum disorders $530,265
University of California, Los Angeles Dr. Brigitte N Gomperts Tissue Collection for Disease Modeling Using human induced pluripotent stem cells to improve our understanding of Idiopathic Pulmonary Fibrosis $811,231
University of California, San Francisco Jacquelyn J Maher Tissue Collection for Disease Modeling iPSC-derived Hepatocytes as Platforms for Research in Viral Hepatitis and Non-alcoholic Steatohepatitis $791,680
Reza Ardehali Dr. Reza Ardehali MD, PhD New Faculty Physician Scientist Medical School Loan Repayment Program $35,511
Tippi C. Mackenzie Dr. Tippi C. Mackenzie MD New Faculty Physician Scientist Medical School Loan Repayment Program $36,436
Ali Nsair Ali Nsair New Faculty Physician Scientist Medical School Loan Repayment Program $120,312
University of California, San Francisco Dr. Tippi C. Mackenzie MD New Faculty Physician Scientist In Utero Embryonic Stem Cell Transplantation to Treat Congenital Anomalies $2,661,742
Cedars-Sinai Medical Center Dr. Robert H Baloh New Faculty Physician Scientist Human iPSC modeling and therapeutics for degenerative peripheral nerve disease $3,031,737
Stanford University Alan G Cheng New Faculty Physician Scientist Enhancing hair cell regeneration in mouse and human inner ear $3,088,525
University of California, San Francisco Dr. Ophir Klein MD, PhD New Faculty Physician Scientist Stem cell therapy for inflammatory bowel disease $3,019,013
Stanford University Michelle Monje New Faculty Physician Scientist White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” $2,800,526
University of California, San Francisco Jason Harris Pomerantz New Faculty Physician Scientist Characterization of Human Skeletal Muscle Stem Cells for Clinical Application $2,959,014
University of California, San Francisco Ann Capela Zovein New Faculty Physician Scientist Human endothelial reprogramming for hematopoietic stem cell therapy. $2,197,683
University of California, Davis Emanual Michael Maverakis New Faculty Physician Scientist Tunable hydrogels for therapeutic delivery of multipotent stem cells. $2,771,903
University of California, Los Angeles Dr. Ali Nsair MD New Faculty Physician Scientist Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. $2,316,894
Children’s Hospital of Los Angeles Dr. Tracy Cannon Grikscheit M.D. New Faculty Physician Scientist The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation $3,146,160
1 2 3 4 5 6 7 8 9 10 11 12 13 14 … 29